Thermo Fisher Scientific Inc. Share Price Lima
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
585 USD | 0.00% | 0.00% | +13.20% |
Sales 2024 * | 43.01B 3,410B | Sales 2025 * | 46.08B 3,653B | Capitalization | 227B 18,000B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 484B | Net income 2025 * | 7B 555B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 1,902B | Net Debt 2025 * | 19.18B 1,521B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
3 months | +5.79% | ||
6 months | +32.12% | ||
Current year | +13.20% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
Date | Price | Change |
---|---|---|
14/05/24 | 585 | 0.00% |
13/05/24 | 585 | 0.00% |
10/05/24 | 585 | 0.00% |
09/05/24 | 585 | 0.00% |
08/05/24 | 585 | 0.00% |
End-of-day quote Lima, May 12, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.76% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B | |
+25.48% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TMO Stock